Projects per year
Abstract
The Notch signaling pathway is a direct cell-cell communication system involved in a wide variety of biological processes, and its disruption is observed in several pathologies. The pathway is comprised of a ligand-expressing (sender) cell and a receptor-expressing (receiver) cell. The canonical ligands are members of the Delta/Serrate/Lag-1 (DSL) family of proteins. Their binding to a Notch receptor in a neighboring cell induces a conformational change in the receptor, which will undergo regulated intramembrane proteolysis (RIP), liberating the Notch intracellular domain (NICD). The NICD is translocated to the nucleus and promotes gene transcription. It has been demonstrated that the ligands can also undergo RIP and nuclear translocation, suggesting a function for the ligands in the sender cell and possible bidirectionality of the Notch pathway. Although the complete mechanism of ligand processing is not entirely understood, and its dependence on Notch receptors has not been ruled out. Also, ligands have autonomous functions beyond Notch activation. Here we review the concepts of reverse and bidirectional signalization of DSL proteins and discuss the characteristics that make them more than just ligands of the Notch pathway.
Original language | English |
---|---|
Pages (from-to) | 377-398 |
Journal | Critical Reviews in Biochemistry and Molecular Biology |
Volume | 57 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Sept 2022 |
MoE publication type | A2 Review article in a scientific journal |
Keywords
- Notch pathway
- DSL ligands
- reversible signaling
- bidirectional
- Regulated Intramembrane Proteolysis (RIP)
- ADAM
- γ-secretase
- PDZ
Fingerprint
Dive into the research topics of 'Reversible and bidirectional signaling of notch ligands'. Together they form a unique fingerprint.Projects
- 3 Finished
-
Notch counteracts replication stress to prevent cancer cell senescence
Sahlgren, C. (Principal Investigator)
Cancer Foundation Finland, Sigrid Jusélius Foundation
01/05/20 → 31/12/23
Project: Foundation
-
AKT-mediated post-translational regulation of NOTCH3 – decoding the Notch phosphorylation switchboard for targeted therapies in cancer
Sahlgren, C. (Principal Investigator)
01/09/19 → 30/09/22
Project: Foundation
-
CellMech: Center of Excellence in Cellular Mechanostasis
Sahlgren, C. (Principal Investigator), Sistonen, L. (Principal Investigator), Eriksson, J. (Principal Investigator), Toivola, D. (Principal Investigator), Meinander, A. (Principal Investigator), Cheng, F. (Principal Investigator) & Jacquemet, G. (Principal Investigator)
01/03/19 → 29/02/24
Project: Foundation